(Total Views: 396)
Posted On: 01/06/2021 2:56:38 PM
Post# of 153822
Re: MD VIROLOGIST #71487
If the price is right. But the issue remains. If our data is strong, and we get an EUA the price would need to be pretty strong.
An offer won't come before data.
If the share price runs to say $20, and revenue unlocks the potential of multiple indications it will be difficult to present an offer that gets majority approval.
An offer won't come before data.
If the share price runs to say $20, and revenue unlocks the potential of multiple indications it will be difficult to present an offer that gets majority approval.
(2)
(0)
